We used a statistic called the Zscore to assess and rank

companies based on their

financial health.
The statistical measure includes
income statement and balance
sheet ratios to develop a
composite measure for each
company, which is known as the
Z-score.
It was originally developed by Dr.
Edward Altman of New York
University, and has been refined
over time to become the gold
standard of financial risk
assessment.
While most firms in the
pharmaceutical industry are well
above the parameters which indicate
cause for concern, it is a helpful
technique to rank firms into four